Papers
3
Total Citations
103
H-Index
3
About
Dr. Carmen Mir is a leading urologic oncologist whose research focuses on advancing minimally invasive surgical approaches for kidney and bladder cancers. Her major contributions center on comparing robotic and open surgical techniques to optimize oncological outcomes while reducing patient morbidity. As a key member of the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group, Dr. Mir has led pivotal studies demonstrating that robotic partial nephrectomy can be a safe and effective alternative to radical nephrectomy for complex and large renal masses, including clinical T2a tumors. Her 2020 propensity-matched study, with 64 citations, provided crucial evidence supporting nephron-sparing surgery in this challenging population. More recently, her 2023 analysis of complex renal masses, cited 36 times, further clarified the comparative oncological outcomes and complication profiles. Dr. Mir has also contributed decade-long, single-surgeon experience comparing open and robotic radical cystectomy with intracorporeal neobladder, offering valuable long-term data on perioperative and functional outcomes. Her work directly informs surgical decision-making, helping urologists balance cancer control with quality of life for patients with urologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3